Artificial intelligence in COVID-19 drug repurposing

Искусственный интеллект в репозиционировании лекарственных препаратов для лечения COVID-19
Jian Tang, Ruth Nussinov, Yadi Zhou, Feixiong Cheng, Fei Wang
2020-09-18

COVID-19 drug repurposingartificial intelligencenetwork medicineprecision medicinetherapeutic development
Drug repurposing or repositioning is a technique whereby existing drugs are used to treat emerging and challenging diseases, including COVID-19. Drug repurposing has become a promising approach because of the opportunity for reduced development timelines and overall costs. In the big data era, artificial intelligence (AI) and network medicine offer cutting-edge application of information science to defining disease, medicine, therapeutics, and identifying targets with the least error. In this Review, we introduce guidelines on how to use AI for accelerating drug repurposing or repositioning, for which AI approaches are not just formidable but are also necessary. We discuss how to use AI models in precision medicine, and as an example, how AI models can accelerate COVID-19 drug repurposing. Rapidly developing, powerful, and innovative AI and network medicine technologies can expedite therapeutic development. This Review provides a strong rationale for using AI-based assistive tools for drug repurposing medications for human disease, including during the COVID-19 pandemic.
1
AI models can support precision medicine and accelerate the identification of candidate COVID-19 repurposing treatments.
2
Artificial intelligence and network medicine can integrate large-scale information to define disease mechanisms, identify therapeutic targets, and support drug repositioning.
3
Drug repurposing can reduce therapeutic development timelines and overall costs for emerging diseases such as COVID-19.
4
Rapidly advancing AI and network-medicine technologies may expedite therapeutic development, although the abstract presents a rationale and framework rather than specific clinical efficacy results.
5
The review provides guidelines for applying AI to accelerate drug repurposing, emphasizing that these approaches are increasingly necessary in the big-data era.

COVID-19 drug repurposing

Artificial-intelligence approaches for accelerating and guiding drug repurposing, including target identification and precision-medicine applications

Publication Details
Publication Date
2020-09-18
Journal
Publisher
ISSN
Cited by
632
Access Type
Author Information
Authors
Jian Tang
Ruth Nussinov
Yadi Zhou
Feixiong Cheng
Fei Wang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%